Zhigang M. Hu

299 Qingyang Road
Wuxi, 214023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 147 publications

Metformin counteracts lipid accumulation and cell proliferation in hepatocellular carcinoma via regulating METTL3-mediated m6A methylation.

Metformin counteracts lipid accumulation and cell proliferation in hepatocellular carcinoma via regulating METTL3-mediated m6A methylation.

Journal: Cell cycle (Georgetown, Tex.)

Published: May 03, 2026

Erythrocyte membrane-liposome coating sustains circulation stability and targeted tumor therapy of CAR-T cells.

Erythrocyte membrane-liposome coating sustains circulation stability and targeted tumor therapy of CAR-T cells.

Journal: Frontiers in immunology

Published: January 29, 2026

Mechanical preconditioning by shear stress enhances memory formation and anti-tumor function of CAR-T cells.

Mechanical preconditioning by shear stress enhances memory formation and anti-tumor function of CAR-T cells.

Journal: Cancer immunology, immunotherapy : CII

Published: January 12, 2026

The methyltransferase METTL3 promotes the progression of breast cancer cells via regulating EGF m6A modification.

The methyltransferase METTL3 promotes the progression of breast cancer cells via regulating EGF m6A modification.

Journal: Cell cycle (Georgetown, Tex.)

Published: October 09, 2025

Molecular Imaging of Diabetes-Associated Glutathione S-Transferase Dysregulation Using a Smart Activatable Probe.

Molecular Imaging of Diabetes-Associated Glutathione S-Transferase Dysregulation Using a Smart Activatable Probe.

Journal: Bioconjugate chemistry

Published: September 19, 2025

Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors.

Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 26, 2025

CCR2/CXCR6 enhances tumor infiltration and antitumor efficacy of MSLN CAR-T cells.

CCR2/CXCR6 enhances tumor infiltration and antitumor efficacy of MSLN CAR-T cells.

Journal: Cellular and molecular life sciences : CMLS

Published: July 24, 2025

Microbiota-derived butyrate potentiates MSLN CAR-T cell therapy by metabolic reprogramming and extracellular matrix remodeling.

Microbiota-derived butyrate potentiates MSLN CAR-T cell therapy by metabolic reprogramming and extracellular matrix remodeling.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 17, 2025

An activatable molecular probe for early detection of obesity-associated aminopeptidase N activity in vivo and in serum.

An activatable molecular probe for early detection of obesity-associated aminopeptidase N activity in vivo and in serum.

Journal: Chemical communications (Cambridge, England)

Published: June 04, 2025

Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer.

Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer.

Journal: Journal of translational medicine

Published: May 04, 2025

Antigen escape in CAR-T therapy: A tumor microenvironment perspective from hematological to solid tumors.

Antigen escape in CAR-T therapy: A tumor microenvironment perspective from hematological to solid tumors.

Journal: International journal of cancer

Published: April 29, 2025

APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC.

APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC.

Journal: Genes & diseases

Published: March 10, 2025

Showing 1-12 of 147

Last Updated: 09/26/2026